EX-23.1 5 a19-9652_1ex23d1.htm EX-23.1

Exhibit 23.1



Consent of Independent Registered Public Accounting Firm


We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of Milestone Pharmaceuticals Inc. of our report dated February 18, 2019, except for the effects of the reverse share split described in Note 1, as to which the date is April 29, 2019, relating to the consolidated financial statements, which appears in Milestone Pharmaceuticals Inc.’s Registration Statement on Form S-1, as amended (No. 333-230846).


/s/PricewaterhouseCoopers LLP(1)


Montreal, Québec, Canada

May 9, 2019


(1) CPA auditor, CA, public accountancy permit No. A113048


PricewaterhouseCoopers LLP/s.r.l./s.e.n.c.r.l.

1250 René-Lévesque Boulevard West, Suite 2500, Montréal, Quebec, Canada H3B 4Y1

T: +1 514 205 5000, F: +1 514 876 1502, www.pwc.com/ca


“PwC” refers to PricewaterhouseCoopers LLP/s.r.l./s.e.n.c.r.l., an Ontario limited liability partnership.